当前位置:首页 > 文献互助 > 互助详情

YN1548: A novel small-molecule agonist of human glucagon-like peptide-1 receptor for the treatment of type 2 diabetes mellitus and obesity复制

用户lzQQTKAQxKiY 1个月前 89 10 已完结

1. 系统已在2026-08-11 11:47:06对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

IG Je, TK Kim, HJ Lee, MY Lee, KM An, JT Park…
European Journal of …, 2025
Elsevier
Type 2 diabetes mellitus (T2DM) and obesity are the major global health concerns. Glucagon-like peptide-1 (GLP-1) receptor agonists are effective incretin-based treatments for T2DM and obesity. The patient compliance of peptide-based GLP-1 receptor agonists is limited due to subcutaneous administration. This study aimed to develop small-molecule GLP-1 receptor agonists that can be administered orally. Pharmacological properties of YN1548 were evaluated using in vitro assays in Chinese hamster ovary (CHO) cells …

互助时间线

2026-08-04 13:08:27 [完结求助]

楼主确认了jodie0105应助的文件是正确的, 求助状态变成 已完结

2026-08-04 11:47:06 [上传文件]

jodie0105上传了文件(pdf 4.11 MB), 求助状态变成 待确认

2026-08-04 11:39:05 [发起求助]

最新发布的求助